Type 1 Diabetes TrialNet--an international collaborative clinical trials network
about
The Role of Gluten in Celiac Disease and Type 1 DiabetesPreclinical lupusPreclinical rheumatoid arthritis (autoantibodies): an updated reviewPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEMolecular Interactions Governing Autoantigen Presentation in Type 1 DiabetesType 1 diabetes research: Newer approaches and exciting developments.Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetesRisk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function.Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes.Testing agents for prevention or reversal of type 1 diabetes in rodents.Immune intervention in type 1 diabetes.Antigen-specific therapeutic approaches in Type 1 diabetesOral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 DiabetesZinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesSibling method increases risk assessment estimates for type 1 diabetes.Primary and secondary prevention of Type 1 diabetesImmunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants.Inducing immune tolerance: a focus on Type 1 diabetes mellitus.Can rheumatoid arthritis be prevented?Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Teplizumab therapy for type 1 diabetes.Diabetes technology and treatments in the paediatric age group.Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Building and Validating a Prediction model for Pediatric Type 1 Diabetes Risk Using Next Generation Targeted Sequencing of Class II HLA Genes.Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure.Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Longitudinal monitoring of gene expression in ultra-low-volume blood samples self-collected at home.Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes.Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development?The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults.Understanding and preventing type 1 diabetes through the unique working model of TrialNet.The Journey of Islet Cell Transplantation and Future Development.Impact of islet transplantation on diabetes complications and quality of life.
P2860
Q26783642-C980236A-DA02-46EB-8F38-DF1C79C2E21BQ26863306-677F41CD-6585-4FAB-A295-7E8CA4BE68A1Q26863441-03942608-75CA-4738-B438-5E13A3D7D410Q27003201-AAE938CA-614E-45E0-92F7-B3F967696A67Q28084487-52219F6E-5DF1-457F-A711-8FD9CF100ECBQ33616052-6590C3B8-051C-4F6A-9D36-56DA5DF5424DQ33751549-60D6671D-CED8-4EE2-A306-A7E8FD8EE2A7Q33789346-1E7B9CA1-04E1-4B0C-A011-7DDCF8D0D37AQ34086635-23999ABE-42B7-42C5-899F-0B8B2A9B68D7Q34448607-0A739ED6-8EF0-4744-A417-C4C1E0BF714BQ34604619-1DD0A3D0-FAD8-4428-B030-C2C359359EC3Q34921581-0BB6926C-3FF1-47D4-AD66-634EF9A1830EQ34983677-82CC1D3D-6F5E-4CBA-9E6A-5BBD756B460BQ35226251-DE2178A1-DACB-4E7C-928F-0A801A33882EQ35762883-944D03FE-FDCA-4B9E-ADA4-B7F5D163DCBDQ35897441-14BEB06D-FB97-4E02-905D-8014443CDAFDQ35976503-8576B0A5-1843-41CD-8831-AA4BC5496532Q36373147-D146D955-A8AE-49D5-9910-AFF4B0AF1DA2Q36631971-3453431A-6397-4B00-86BD-D600C8B83068Q36913132-AF8A2099-2495-4548-B627-0FE08EAF4C25Q37368421-4338FA1B-529B-4428-8148-A1ABCB1E12CAQ37542678-C2959876-5173-44FF-9CFD-C3A299319AF1Q37589108-12E4AEDA-9081-418D-BF54-CFE0D4B76E00Q37659402-41238795-A79B-4D4A-9429-36ECEF8EEDE9Q37679927-93B6A918-E66D-4019-8978-3968F0463027Q37842725-F47EE10E-2918-4CBE-9A97-8ADA657BC7AEQ38161556-A5E7DF44-EC15-4E6B-B449-0CB2057D6E9CQ38645059-F0B40607-D40E-4934-99BB-8A91BD729432Q38650009-F75DAE08-99B7-42FB-96B8-C4D08A7DF8A6Q38692770-66C5A053-C7D5-469C-8881-A88C0F9F5658Q38828063-A5AB0C34-4C58-47CC-8062-CE6E70A8F966Q38837965-F18D2DFA-1ABB-4C31-A1C9-0DB39D0CD1D4Q39069291-4F130BD3-38A2-48E9-8FED-D79B2C107015Q39596760-B7142FC4-6BFF-4A50-B6A9-AE509CC2E605Q45953659-A79D091C-7DBC-47AF-B048-C4DB7A30CCB4Q46048892-585331BD-CE55-4968-B64F-8012A18BDD16Q46140989-98BD4E3F-4DBD-4475-959F-3DAD6643EA92Q46486153-3BCB8F86-F036-4D9E-BDAC-442757389F08Q47696722-0FC80500-285B-4CBD-A9AA-94C52A884FAEQ48631653-62C2CFD7-F65B-4C6B-A89F-87ECE5C6E3BE
P2860
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@ast
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@en
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@nl
type
label
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@ast
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@en
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@nl
prefLabel
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@ast
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@en
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@nl
P2093
P2860
P356
P1476
Type 1 Diabetes TrialNet--an international collaborative clinical trials network
@en
P2093
Carla J Greenbaum
Ellen Leschek
Jay S Skyler
Lisa Rafkin-Mervis
Lisa Spain
Peter Savage
Type 1 Diabetes TrialNet Study Group
P2860
P356
10.1196/ANNALS.1447.054
P407
P577
2008-12-01T00:00:00Z